CONMED
CNMD
227 hedge funds and large institutions have $2.13B invested in CONMED in 2020 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 78 increasing their positions, 79 reducing their positions, and 36 closing their positions.
26% more call options, than puts
Call options by funds: $6.3M | Put options by funds: $4.98M
26% more capital invested
Capital invested by funds: $1.69B → $2.13B (+$440M)
0.03% more ownership
Funds ownership: 103.7% → 103.73% (+0.03%)
0% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 36
0% less funds holding
Funds holding: 228 → 227 (-1)
1% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 79
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$46.3M |
| 2 |
SCM
Scopia Capital Management
New York
|
+$45M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$44.3M |
| 4 |
CVA
Ceredex Value Advisors
Orlando,
Florida
|
+$22.7M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$16.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$60.2M |
| 2 |
HM
HealthCor Management
New York
|
-$39.4M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$26.9M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$17.9M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$15.4M |
CNMD Hedge Fund Activity: Q2 2020 in Review
227 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2020, worth a combined $2.13B — up 26% from $1.69B a quarter earlier.
Fund positioning in CNMD was balanced in Q2 2020: 36 funds opened new positions, 36 closed out, 78 added to existing stakes and 79 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $46.3M. The largest seller was Capital Research Global Investors, cutting an estimated $60.2M.
- 227 institutional investors held CONMED (CNMD) as of Q2 2020, down from 228 in Q1 2020.
- Funds reported $2.13B of CONMED stock for Q2 2020, up 26% quarter-over-quarter.
- 36 funds opened new CONMED positions in Q2 2020 and 36 closed out, a net change of 0 holders.
- The largest CONMED buyer in Q2 2020 was Point72 Asset Management, an estimated $46.3M added.
- The largest CONMED seller in Q2 2020 was Capital Research Global Investors, an estimated $60.2M sold.
Based on aggregated 13F filings for Q2 2020.